Barclays »

Altimmune shares owned by Barclays

Quarter-by-quarter ownership of Altimmune (ALT) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Altimmune

Tip: Access up to 7 years of quarterly data

All positions including Altimmune held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Altimmune by Barclays

Quarter filed Position value Share count Share price at filing
2024-09-30 $956k 156k 6.14
2024-06-30 $535k 81k 6.63
2024-03-31 $1.3M 125k 10.17
2023-12-31 $814k 72k 11.24
2023-09-30 $482k 180k 2.67
2023-06-30 $396k 111k 3.55
2023-03-31 $957k 227k 4.22
2022-12-31 $5.9M 361k 16.45
2022-09-30 $2.4M 188k 12.77
2022-06-30 $13M 1.1M 11.70
2022-03-31 $7.0M 1.2M 6.09
2021-12-31 $10M 1.1M 9.16
2021-09-30 $3.2M 283k 11.31
2021-06-30 $670k 68k 9.86
2021-03-31 $464k 33k 14.14
2020-12-31 $319k 28k 11.28
2020-09-30 $372k 28k 13.19
2020-06-30 $1.3M 120k 10.71